COMMUNIQUÉS West-GlobeNewswire

XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer
18/10/2017
AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan [...]
Arix Bioscience notes Harpoon Therapeutics' immuno-oncology collaboration with AbbVie
18/10/2017
Arix Bioscience notes Harpoon Therapeutics' immuno-oncology collaboration with AbbVie LONDON, 18 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science company supporting [...]
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC
18/10/2017
New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the [...]
Crown Bioscience partagera son expertise scientifique dans l'évaluation préclinique des molécules expérimentales anticancer lors de la Conférence internationale sur les cibles moléculaires et...
18/10/2017
Crown Bioscience partagera son expertise scientifique dans l'évaluation préclinique des molécules expérimentales anticancer lors de la Conférence internationale sur les cibles moléculaires et les agents thérapeutiques [...]
uniQure Presents New Preclinical Data on AMT-130 in Huntington's Disease at the ESGCT 25th Anniversary Congress in Berlin
18/10/2017
One-time Administration of AMT-130 Demonstrates Survival Benefit and Functional Improvement of Huntington's Disease Symptoms in Preclinical Study IND-enabling Toxicology Study Initiated LEXINGTON, Mass. and AMSTERDAM, [...]
Enzymatica AB: Complete article from COLDPREV I study published - strengthens documentation for ColdZyme
18/10/2017
COLDPREV I Eng 171018 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Conférence de presse du mardi de la Conférence mondiale sur le cancer du poumon : des preuves à l'appui des interventions novatrices contre le cancer du poumon
18/10/2017
YOKOHAMA, Japon, le 18 octobre 2017 (GLOBE NEWSWIRE) - La conférence de presse organisée aujourd'hui à l'occasion de la 18 e Conférence mondiale sur le cancer du poumon (World Conference on Lung Cancer - WCLC) de l' [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
18/10/2017
FIT Biotech Oy Company release October 18, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Photocure ASA: FDA grants priority review for Cysview® supplemental New Drug Application (sNDA)
18/10/2017
Oslo, Norway, October 18, Photocure ASA (OSE: PHO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Cysview ® on a priority review basis. [...]
Novartis drug Revolade® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)
18/10/2017
Nearly 70% of patients maintained platelet counts of >=30×10 9 /L without rescue therapy for prolonged periods, reducing the overall risk of bleeding More than one-third of patients permanently stopped one or more [...]
MedDay to Participate in the 7th Joint ECTRIMS - ACTRIMS Meeting in Paris, France
18/10/2017
MedDay to Participate in the 7 th Joint ECTRIMS - ACTRIMS Meeting in Paris, France Sponsors a satellite symposium: 'New horizons in progressive multiple sclerosis' Oral presentation of 24-month MRI data from MS-SPI [...]
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer
18/10/2017
YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new [...]
Weifa ASA - minutes of extraordinary general meeting
17/10/2017
Following the compulsory acquisition of the remaining shares in Weifa ASA that was effected on 12 October 2017, an extraordinary general meeting was held on 17 October 2017 in Weifa ASA. Please find attached the minutes [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
17/10/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
17/10/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Conférence de presse du lundi à l'occasion de la Conférence mondiale sur le cancer du poumon : Recherches sur les dangers du tabagisme et les interventions du cancer du poumon
17/10/2017
YOKOHAMA, Japon, le 17 octobre 2017 (GLOBE NEWSWIRE) - Lors de la conférence de presse organisée aujourd'hui à l'occasion de la 18 e Conférence mondiale sur le cancer du poumon (World Conference on Lung Cancer - WCLC) [...]
Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds
17/10/2017
SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]
PCI Biotech: Employee share option scheme
17/10/2017
Oslo, 17 October 2017 In accordance with the authorisation granted by the Annual General Meeting 29 May 2017, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 90,000 share options to key [...]
Saniona AB: Saniona's Partner Cadent Therapeutics Receives Milestone from Novartis
17/10/2017
PRESS RELEASE October 17, 2017 Saniona, a leading biotech company in the field of ion channels, today announced that its collaboration partner, Cadent Therapeutics (former Luc Therapeutics), has earned a milestone [...]

Pages